Immunological approaches have been used to demonstrate the presence of advanced glycation end-products (AGEs) in several human and experimental animal tissues. We previously prepared polyclonal and monoclonal anti-AGE antibodies by immunizing AGE-modified proteins such as BSA and RNase. Although these antibodies contributed to demonstrate the presence of AGE-modified protein in vivo, the epitope structure of these antibodies had not been identified. We subsequently prepared several antibodies against AGE structures such as pentosidine, pyrraline, 3-deoxyglucosone imidazolone and N∊-(carboxyethyl)lysine by immunizing single AGE structures. These structure-specific antibodies have greatly helped broaden our understanding of AGE structures in aging and age-enhanced disease process. Monoclonal anti-AGE antibody is also used for the identification of major AGE structures in some pathological tissues, such as human atherosclerosis lesions. Based on the strategy, we successfully identified a novel AGE structure named glycolaldehyde-pyridine, which is the major antigenic AGE derived from glycolaldehyde. Therefore a monoclonal antibody library for AGE structures has served an important role in the elucidation of the biological significance of AGE.
Conference Article| December 01 2003
Application of monoclonal antibody libraries for the measurement of glycation adducts
S. Horiuchi 1
Department of Medical Biochemistry, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Honjo 1-1-1, Kumamoto 860-8556, Japan
1To whom correspondence should be addressed (e-mail firstname.lastname@example.org).
Search for other works by this author on:
Biochem Soc Trans (2003) 31 (6): 1438–1440.
- Views Icon Views
- Share Icon Share
R. Nagai, S. Horiuchi; Application of monoclonal antibody libraries for the measurement of glycation adducts. Biochem Soc Trans 1 December 2003; 31 (6): 1438–1440. doi: https://doi.org/10.1042/bst0311438
Download citation file: